RecruitingNot ApplicableNCT04527445
Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
Reduction in Fluoroscopy Radiation Exposure During Lead Implantation for Sacral Neuromodulation: A Randomized Prospective Study
Sponsor
Loma Linda University
Enrollment
44 participants
Start Date
Jun 1, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.
Eligibility
Min Age: 18 YearsMax Age: 89 Years
Inclusion Criteria1
- Patients undergoing lead implantation for sacral neuromodulation that have overactive bladder as defined by urinary urgency, frequency, nocturia with or without urgency incontinence.
Exclusion Criteria1
- neurogenic bladder, BMI \>40, or peripheral neuropathy.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREReduced radiation fluoroscopy
See previous information about each arm
PROCEDUREConventional fluoroscopy
See previous information about each arm
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04527445
Related Trials
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
NCT056520231 location
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS
NCT060727031 location
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
NCT0651114119 locations
Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis
NCT057726371 location
TReating Incontinence for Underlying Mental and Physical Health
NCT053622922 locations